China Life Insurance (02628) plans to invest 4.999 billion yuan to establish a partnership with China Life Insurance

According to Zhitong Finance App, China Life Insurance (02628) announced that the company (as a limited partner) intends to enter into a partnership agreement with China Life Insurance (as a general partner) before December 31, 2026 to establish a partnership. The total amount of capital pledged by all partners of the partnership enterprise is RMB 5 billion, of which the Company has pledged capital of RMB 4.999 billion and China Life Insurance has pledged capital of RMB 1 million. China Life Capital will act as the manager of the partnership.

The target company the partnership plans to invest in provides process support services for design companies and other system companies. It has deep technical accumulation and resource accumulation in the semiconductor industry, outstanding core technical advantages, and a complete R&D system. As an important force of state-owned capital, the company's participation in investment in strategic emerging industries such as semiconductors through this transaction is not only a responsibility to implement the national strategy for financial services, but also a concrete expression of implementing long-term capital and patient capital responsibility.

The semiconductor field has complex technical systems, high process barriers, and a long upstream and downstream industrial chain construction cycle. Achieving large-scale development requires high comprehensive support capabilities, and there is broad space for medium- to long-term value-added. The target company has built a large-scale production layout based on technology accumulation and operational experience, and has industry-leading supporting delivery capabilities. This transaction is an important reflection of the company's implementation of innovation-driven development decisions and deployments. It helps to increase the return on insurance fund investment and meets insurance fund allocation requirements.